- Home
- ARWR vs CCK Comparison
ARWR vs CCK Comparison
Compare ARWR & CCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARWR | CCK |
|---|---|---|
| Founded | 2003 | 1906 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Containers/Packaging |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.1B | 11.3B |
| IPO Year | 2009 | 2003 |
Fundamental Metrics
Financial Performance| Metric | ARWR | CCK |
|---|---|---|
| Price | $58.19 | $105.08 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 15 |
| Target Price | $81.50 | ★ $123.27 |
| AVG Volume (30 Days) | ★ 1.9M | 907.4K |
| Earning Date | 05-08-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 0.99% |
| EPS Growth | ★ 99.80 | 79.72 |
| EPS | 0.22 | ★ 6.38 |
| Revenue | $16,142,321.00 | ★ $11,665,000,000.00 |
| Revenue This Year | N/A | $5.26 |
| Revenue Next Year | N/A | $2.40 |
| P/E Ratio | $269.95 | ★ $16.54 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $10.66 | $75.98 |
| 52 Week High | $76.76 | $116.62 |
Technical Indicators
Market Signals| Indicator | ARWR | CCK |
|---|---|---|
| Relative Strength Index (RSI) | 36.19 | 36.55 |
| Support Level | $36.34 | $98.85 |
| Resistance Level | $66.37 | $105.91 |
| Average True Range (ATR) | 3.00 | 2.59 |
| MACD | -0.49 | -1.45 |
| Stochastic Oscillator | 13.32 | 14.61 |
Price Performance
Historical ComparisonAbout ARWR Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc is an American biotechnology company. Its main target is the development of medicine to treat diseases with a genetic origin, characterized by the overproduction of one or more proteins. Its medical solutions are aimed at the genes that trigger the diseases. Its portfolio includes drugs targeting cardiovascular, Cardiometabolic, Central Nervous System, Pulmonary, Liver, Muscular, and Complement Mediated Disease. It majority products are liver disease curable.
About CCK Crown Holdings Inc.
Crown Holdings is one of the world's largest producers of metal packaging. The company manufactures beverage cans, metal food cans, and closures as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.